Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether an intravenous salt solution called "Plasmalyte" causes less abnormality of the body's acid levels than a solution called "Normal Saline."
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Electrolyte-containing intravenous fluids are routinely administered to patients in the first few hours after acute traumatic injury. Although Normal Saline (0.9% sodium chloride) is commonly used in this setting, it causes a hyperchloremic acidosis that may exacerbate metabolic derangements that occur after acute injury. Plasmalyte A is a solution that more closely matches physiologic electrolyte levels. In this study, we will evaluate whether Plasmalyte A results in less disturbance of the base deficit 24 hours following traumatic injury than does Normal Saline.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Plasmalyte Administration of Plasmalyte A as the standard intravenous fluid during the first 24 hours after arrival to the hospital |
Other: Plasmalyte A
Intravenous fluid
|
Active Comparator: Normal Saline Administration of Normal Saline as the standard intravenous fluid during the first 24 hours after arrival to the hospital |
Other: Normal Saline
Intravenous fluid
|
Outcome Measures
Primary Outcome Measures
- Change in the base deficit [24 hours after randomization]
Base deficit at 24 hours after randomization minus the base deficit at randomization
Secondary Outcome Measures
- Mortality [Hospital discharge]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Triaged upon arrival to the hospital as severely injured
-
At least 18 years of age
-
Meets at least one of the following criteria:
-
Intubated or likely to become intubated within 60 minutes of arrival at the hospital
-
Likely to need an operation within 60 minutes of arrival
-
Received or likely to receive a blood transfusion within 60 minutes of arrival
Exclusion Criteria:
-
Greater than 60 minutes since arrival at the hospital
-
Death likely within 48 hours
-
Transfer from another hospital
-
Pre-existing renal failure requiring dialysis
-
Pregnancy
-
Prisoner status
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of California, Davis, Medical Center | Sacramento | California | United States | 95817 |
Sponsors and Collaborators
- University of California, Davis
- Bayer
Investigators
- Study Director: Garth H. Utter, MD, University of California, Davis
- Principal Investigator: Lynette A. Scherer, MD, University of California, Davis
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 200917793